HighCape Capital Acquisition Corporation (CAPA) Noticias

Where is my mirror Television? :)

Investor presentation...

https://assets.website-files.com/5e3ba888b619ec2d758ec4cb/602e47a1c5496f3a68af7fed_Quantum-Si%20PIPE%20Master%20Final%20Feb%2018.pdf

CAPA and Quantum-Si, Pioneer in Chip-Based Proteomics

NEW YORK and GUILFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (“Quantum-Si”, "QSi" or the "Company"), a pioneer in next generation semiconductor chip-based proteomics, and HighCape Capital Acquisition Corp. (Nasdaq: CAPA) (“HighCape”), a special purpose acquisition company sponsored by HighCape Capital LP, announced today that they have entered into a definitive business combination agreement. Upon completion of the transaction, the combined company's Class A common stock is expected to be traded on The Nasdaq Stock Market (“Nasdaq”) under the symbol "QSI".

Company Overview
Quantum-Si has created the first next-generation protein sequencing platform with the goal of revolutionizing the growing field of proteomics. Our unique semiconductor chip has the power to decode the molecules of life, starting with proteins, and holds the potential to expand the scale of the genomics and proteomics market beyond that of next-generation DNA sequencing.

QSi’s end-to-end solution, including Carbon and Platinum, which is on track to launch commercially in 2022 for research use, has the potential to significantly disrupt an existing addressable $21 billion market of pharmaceutical, academic research and drug discovery. The platform also may enable new diagnostic applications in healthcare.

https://www.globenewswire.com/news-release/2021/02/18/2177804/0/en/Quantum-Si-a-Pioneer-in-Semiconductor-Chip-Based-Proteomics-to-Combine-with-HighCape-Capital-Acquisition-Corp.html